Viral proteins that bind double-stranded RNA: Countermeasures against host antiviral responses

Journal of Interferon and Cytokine Research

Volumn 34, Issue 6, 2014, Pages 464-468

  Krug, Robert M ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; DNA BINDING PROTEIN; DOUBLE STRANDED RNA; GAMMA INTERFERON; NONSTRUCTURAL PROTEIN 1; UNCLASSIFIED DRUG; VIRUS NUCLEOPROTEIN; VIRUS PROTEIN; VP35 PROTEIN; RNA BINDING PROTEIN;

AMINO ACID SUBSTITUTION; CRYSTAL STRUCTURE; EBOLA VIRUS; FILOVIRIDAE; HUMAN; HYDROGEN BOND; INFLUENZA VIRUS A; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; TRANSIENT TRANSFECTION; TREATMENT RESPONSE; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM;

ANIMALS; EBOLAVIRUS; HOST-PATHOGEN INTERACTIONS; INFLUENZA A VIRUS; MODELS, MOLECULAR; RNA, DOUBLE-STRANDED; RNA-BINDING PROTEINS; VIRAL PROTEINS;

EID: 84902147952     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2014.0005     Document Type: Review

References (40)

1. Aramini JM, Ma LC, Zhou L, Schauder CM, Hamilton K, Amer BR, Mack TR, Lee HW, Ciccosanti CT, Zhao L, et al. 2011. Dimer interface of the effector domain of non-structural protein 1 from influenza A virus: An interface with multiple functions. J Biol Chem 286:26050-26060
2. Bale S, Julien JP, Bornholdt ZA, Krois AS, Wilson IA, Saphire EO. 2013. Ebolavirus VP35 coats the backbone of doublestranded RNA for interferon antagonism. J Virol 87:10385-10388
3. Basler CF, Mikulasova A, Martinez-Sobrido L, Paragas J, Muhlberger E, Bray M, Klenk HD, Palese P, Garcia-Sastre A. 2003. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol 77:7945-7956. (Pubitemid 36792791
4. Cardenas WB, Loo YM, Gale M, Jr., Hartman AL, Kimberlin CR, Martinez-Sobrido L, Saphire EO, Basler CF. 2006. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J Virol 80:5168-5178
5. Chang HW, Jacobs BL. 1993. Identification of a conserved motif that is necessary for binding of the vaccinia virus E3L gene products to double-stranded RNA. Virology 194:537-547
6. Cheng A, Wong SM, Yuan YA. 2009. Structural basis for dsRNA recognition by NS1 protein of influenza A virus. Cell Res 19:187-195
7. Chien CY, Tejero R, Huang Y, Zimmerman DE, Rios CB, Krug RM, Montelione GT. 1997. A novel RNA-binding motif in influenza A virus non-structural protein 1. Nat Struct Biol 4:891-895. (Pubitemid 27479437
8. Chien CY, Xu Y, Xiao R, Aramini JM, Sahasrabudhe PV, Krug RM, Montelione GT. 2004. Biophysical characterization of the complex between Double-stranded RNA and the N-Terminal domain of the NS1 protein from influenza A virus: Evidence for a novel RNA-binding mode. Biochemistry 43:1950-1962. (Pubitemid 38233257
9. Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, Carnero E, Farzan M, Inoue S, Jung JU, Garcia-Sastre A. (2009). Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5:439-449
10. Gale M, Jr., Katze MG. 1998. Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol Ther 78:29-46. (Pubitemid 28178928
11. Geisbert TW, Hensley LE. 2004. Ebola virus: New insights into disease aetiopathology and possible therapeutic interventions. Expert Rev Mol Med 6:1-24
12. Greenspan D, Palese P, Krystal M. 1988. Two nuclear location signals in the influenza virus NS1 nonstructural protein. J Virol 62:3020-3026
13. Hartman AL, Bird BH, Towner JS, Antoniadou ZA, Zaki SR, Nichol ST. 2008a. Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus. J Virol 82:2699-2704. (Pubitemid 351329161
14. Hartman AL, Ling L, Nichol ST, Hibberd ML. 2008b. Wholegenome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein. J Virol 82:5348-5358. (Pubitemid 351705242
15. Hartman AL, Towner JS, Nichol ST. 2004. A C-Terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus. Virology 328:177-184. (Pubitemid 39349467
16. Hartmann R, Justesen J, Sarkar SN, Sen GC, Yee VC. 2003. Crystal structure of the 2'-specific and double-stranded RNA-Activated interferon-induced antiviral protein 2'-5'-oligoadenylate synthetase. Mol Cell 12:1173-1185. (Pubitemid 37487926
17. Hastie KM, Bale S, Kimberlin CR, Saphire EO. 2012. Hiding the evidence: Two strategies for innate immune evasion by hemorrhagic fever viruses. Curr Opin Virol 2:151-156
18. Hatada E, Fukuda R. 1992. Binding of influenza A virus NS1 protein to dsRNA in vitro. J Gen Virol 73:3325-3329. (Pubitemid 23014192
19. Imani F, Jacobs BL. 1988. Inhibitory activity of the interferoninduced protein kinase is associated with the reovirus serotype 1 s3 protein. Proc Natl Acad Sci U S A 88:7887-7891
20. Jiang F, Ramanathan A, Miller MT, Tang GQ, Gale M, Jr., Patel SS, Marcotrigiano J. 2011. Structural basis of RNA recognition and activation by innate immune receptor RIG-I. Nature 479:423-427
21. Kerry PS, Ayllon J, Taylor MA, Hass C, Lewis A, Garcia-Sastre A, Randall RE, Hale BG, Russell RJ. 2011. A transient homotypic interaction model for the influenza A virus NS1 protein effector domain. PLoS One 6:e17946
22. Kimberlin CR, Bornholdt ZA, Li S, Woods VL, Jr., MacRae IJ, Saphire EO. 2010. Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression. Proc Natl Acad Sci U S A 107:314-319
23. Kowalinski E, Lunardi T, McCarthy AA, Louber J, Brunel J, Grigorov B, Gerlier D, Cusack S. 2011. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 147:423-435
24. Krug RM, Fodor E. 2013. The virus genome and its replication. In: Webster RG, Braciale TJ, Lamb RA, editors. Influenza textbook, 2nd ed. Hoboken (NJ): Wiley-Blackwell, p 57-66
25. Krug RM, Garcia-Sastre A. 2013. The NS1 protein: A master regulator of host and viral functions. In: Webster RG, Braciale TJ, Lamb RA, editors. Influenza textbook, 2nd ed. Hoboken (NJ): Wiley-Blackwell, p 114-132
26. Leung DW, Prins KC, Borek DM, Farahbakhsh M, Tufariello JM, Ramanan P, Nix JC, Helgeson LA, Otwinowski Z, Honzatko RB, et al. 2010. Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35. Nat Struct Mol Biol 17:165-172
27. Liu J, Lynch PA, Chien CY, Montelione GT, Krug RM, Berman HM. 1997. Crystal structure of the unique RNA-binding domain of the influenza virus NS1 protein. Nat Struct Biol 4:896-899. (Pubitemid 27479438
28. Lu Y, Wambach M, Katze MG, Krug RM. 1995. Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology 214:222-228
29. Melen K, Kinnunen L, Fagerlund R, Ikonen N, Twu KY, Krug RM, Julkunen I. 2007. Nuclear and nucleolar targeting of influenza A virus NS1 protein: Striking differences between Different virus subtypes. J Virol 81:5995-6006. (Pubitemid 46847036
30. Min J-Y, Krug RM. 2006. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2'-5' OAS/RNase L pathway. Proc Natl Acad Sci U S A 103:7100-7105
31. Prins KC, Delpeut S, Leung DW, Reynard O, Volchkova VA, Reid SP, Ramanan P, Cardenas WB, Amarasinghe GK, Volchkov VE, et al. 2010. Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs. J Virol 84:3004-3015
32. Robb NC, Chase G, Bier K, Vreede FT, Shaw PC, Naffakh N, Schwemmle M, Fodor E. 2011. The influenza A virus NS1 protein interacts with the nucleoprotein of viral ribonucleoprotein complexes. J Virol 85:5228-5231
33. Silverman RH. 1994. Fascination with 2-5A-dependent RNase: A unique enzyme that functions in interferon action. J Interferon Res 14:101-104. (Pubitemid 24292450
34. Silverman RH. 2007. Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response. J Virol 81:12720-12729. (Pubitemid 350156909
35. Talon J, Horvath CM, Polley R, Basler CF, Muster T, Palese P, Garcia-Sastre A. 2000. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 74:7989-7996. (Pubitemid 30641643
36. Wang W, Riedel K, Lynch K, Chien C, Montelione GT, Krug RM. 1999. RNA-binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. RNA 5:195-205. (Pubitemid 29079280
37. Wang X, Li M, Zheng H, Muster T, Palese P, Beg AA, Garcia-Sastre A. 2000. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol 74:11566-11573. (Pubitemid 32222305
38. Wise HM, Hutchinson EC, Jagger BW, Stuart AD, Kang ZH, Robb N, Schwartzman LM, Kash JC, Fodor E, Firth AE, et al. 2012. Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain. PLoS Pathog 8:e1002998
39. Wright P, Neumann G, Kawaoka. 2012. Orthomyxoviruses. In: Knipe DM, Howley PM, editors. Fields virology, 6th ed. Philadelphia (PA): Lippincott Williams &Wilkins, p 1186-1243
40. Zinzula L, Esposito F, Pala D, Tramontano E. 2012. dsRNA binding characterization of full length recombinant wild type and mutants Zaire ebolavirus VP35. Antiviral Res 93:354-363